Listar00.00. Provisional por tema "Multiple Sclerosis/drug therapy"

Mostrando ítems 1-2 de 2

Pulse immunosuppressive therapy for multiple sclerosis during the SARS-CoV-2 lockdown de-escalation plan: Safety algorithm

Valero-López, G; Carreon-Guarnizo, Ester; Hernández-Clares, R; Iniesta-Martínez, F; Jiménez-Veiga, J; Moreno-Docon, A; Iborra-Bendicho, M-A; Aznar-Robles, E; Hellin-Gil, M-F; Morales-Ortiz, A; Meca-Lallana, J-E (ELSEVIER ESPANA SLU, 2020-07)

INTRODUCTION: The COVID-19 pandemic is changing approaches to diagnosis, treatment, and care provision in multiple sclerosis (MS). During both the initial and peak phases of the epidemic, the administration of disease-modifying ...
Recommendations for vaccination in patients with multiple sclerosis who are eligible for immunosuppressive therapies: Spanish consensus statement

Otero-Romero, S; Rodríguez-García, J; Vilella, A; Ara, J-R; Brieva, L; Calles, C; Carmona, O; Casanova, V; Costa-Frossard, L; Eichau, S; García-Merino, J-A; García-Vidal, C; González-Platas, M; Llaneza, M; Martínez-Gines, M; Meca-Lallana, J-E; Prieto, J-M; Rodríguez-Antiguedad, A; Tintore, M; Blanco, Y; Moral, E (ELSEVIER ESPANA SLU, 2021-01)

BACKGROUND: The recent development of highly effective treatments for multiple sclerosis (MS) and the potential risk of infectious complications require the development of prevention and risk minimisation strategies. ...

Mostrando ítems 1-2 de 2

Buscar en DSpace